Webinar: Key insights on the clinical to commercial transition for autologous therapies

Manufacturers need to understand all of the key aspects of the value chain to ensure an effective transition. 

The journey from clinical to commercial for vein-to-vein autologous therapies can be challenging and complex. Manufacturers need to understand all of the key aspects of the value chain to ensure an effective transition. 

In this webinar, from CAR-TCR 2021, AmerisourceBergen and TrakCel experts share their experiences and discuss how technology advancements, proven solutions and strong partnerships can help deliver an end-to-end solution that is specific to the needs of cell and gene therapy products.

        First Name          
    Last Name          
    Company            
    Email Address     
    Title                   
Country* United States AF AX AL DZ AD AO AI AQ AG AR AM AW AU AT AZ BS BH BD BB BY BE BZ BJ BM BT BO BQ BA BW BV BR IO BN BG BF BI KH CM CA CV KY CF TD CL CN TW CX CC CO KM CG CD CK CR CI HR CU CW CY CZ DK DJ DM DO EC EG SV GQ ER EE ET FK FO FJ FI FR GF PF TF GA GM GE DE GH GI GR GL GD GP GT GG GN GW GY HT HM VA HN HU IS IN ID IR IQ IE IM IL IT JM JP JE JO KZ KE KI KP KR KW KG LA LV LB LS LR LY LI LT LU MO MK MG MW MY MV ML MT MQ MR MU YT MX MD MC MN ME MS MA MZ MM NA NR NP NL NC NZ NI NE NG NU NF NO OM PK PS PA PG PY PE PH PN PL PT QA RE RO RU RW BL SH KN LC MF PM VC WS SM ST SA SN RS SC SL SG SX SK SI SB SO ZA GS SS ES LK SD SR SJ SZ SE CH SY TJ TZ TH TL TG TK TO TT TN TR TM TC TV UG UA AE GB UY UZ VU VE VN VG WF EH YE ZM ZW

   
   
    By submitting this form, I hereby consent to the receipt of marketing materials from
AmerisourceBergen and its affiliates via email and other forms of communications.